. Author manuscript; available in PMC: 2016 Oct 11.

Published in final edited form as: J Acquir Immune Defic Syndr. 2015 Sep 1;70(1):62–66. doi: 10.1097/QAI.0000000000000695

TABLE 4.

SIRs for Cancer Diagnosed Among HIV-Exposed Uninfected Children, New Jersey, 1995–2010

Exposure Type	Observed Cases	Expected Cases (State Reference)^*	SIR^†	LI^‡	UL^‡
Any ARV exposure	3	2.5	1.21	0.25	3.54
Prenatal ARV exposure	3	3.1	0.96	0.20	2.81
Intrapartum ARV exposure	2	2.4	0.83	0.10	2.99
Postnatal ARV exposure	3	3.0	0.99	0.20	2.88

Exposure Type	Observed Cases	Expected Cases (National Reference)^§	SIR^†	LL^‡	UL^‡
Any ARV exposure	3	2.4	1.27	0.26	3.70
Prenatal ARV exposure	3	3.0	1.01	0.21	2.94
Intrapartum ARV exposure	2	2.3	0.87	0.10	3.13
Postnatal ARV exposure	3	2.9	1.03	0.21	3.01

Expected cases determined based on New Jersey cancer rates among children <19 years of age from 1979 to 2005.

^†

Standardized incidence rate (age and sex standardization).

^‡

95% CI.

^§

Expected cases determined based on US cancer rates among children <19 years of age from 1999 to 2009.

LL, lower limit; UL, upper limit.